The latest quarterly R&D expense is $18.43 Million with a QoQ Growth of +43.92%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $18.43M.
$18.43M
$18.43 Million
Q2 FY2026 · 2026-06-30
+43.92%
vs. $12.80M prior quarter
23
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $18.43M | +43.92% | +56.15% |
| Q1 FY2026Period end 2026-03-31 | $12.80M | -5.46% | +40.24% |
| Q4 FY2025Period end 2025-12-31 | $13.54M | +22.53% | +44.56% |
| Q3 FY2025Period end 2025-09-30 | $11.05M | -6.34% | -9.10% |
| Q2 FY2025Period end 2025-06-30 | $11.80M | +29.25% | -2.72% |
| Q1 FY2025Period end 2025-03-31 | $9.13M | -2.55% | -30.59% |
| Q4 FY2024Period end 2024-12-31 | $9.37M | -22.94% | -75.23% |
| Q3 FY2024Period end 2024-09-30 | $12.16M | +0.23% | -80.92% |
| Q2 FY2024Period end 2024-06-30 | $12.13M | -7.78% | -54.95% |
| Q1 FY2024Period end 2024-03-31 | $13.15M | -65.22% | -52.29% |
| Q4 FY2023Period end 2023-12-31 | $37.82M | -40.65% | -0.44% |
| Q3 FY2023Period end 2023-09-30 | $63.73M | +136.61% | +80.50% |
| Q2 FY2023Period end 2023-06-30 | $26.93M | -2.31% | -8.72% |
| Q1 FY2023Period end 2023-03-31 | $27.57M | -27.43% | +10.89% |
| Q4 FY2022Period end 2022-12-31 | $37.99M | +7.61% | +40.10% |
| Q3 FY2022Period end 2022-09-30 | $35.30M | +19.65% | +33.88% |
| Q2 FY2022Period end 2022-06-30 | $29.51M | +18.67% | +41.18% |
| Q1 FY2022Period end 2022-03-31 | $24.86M | -8.31% | +32.60% |
| Q4 FY2021Period end 2021-12-31 | $27.11M | +2.83% | +11.16% |
| Q3 FY2021Period end 2021-09-30 | $26.37M | +26.17% | N/A |
| Q2 FY2021Period end 2021-06-30 | $20.90M | +11.46% | N/A |
| Q1 FY2021Period end 2021-03-31 | $18.75M | -23.13% | N/A |
| Q4 FY2020Period end 2020-12-31 | $24.39M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.